Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is common and increasing in prevalence. Mayo Clinic researchers conducted a study in Circulation to test the hypothesis that cardiac hypertrophy, microvascular rarefaction and myocardial fibrosis are common and related in patients with HFpEF.
Recent Stories for Research
LDL cholesterol (LDL-C)3, an important modifiable risk factor for atherosclerotic cardiovascular disease, is primarily calculated via the Friedewald equation. However, a newly derived equation for LDL-C estimation was recently published that addressed limitations in the commonly used Friedewald LDL-C calculation method. Mayo Clinic researchers completed a study to evaluate the performance of a novel method to classify patients with superior concordance to measured LDL-C compared to the Friedewald method.
Mayo Clinic researchers completed a study in Modern Pathology to examine ERBB2 amplification and protein expression in micropapillary urothelial carcinoma and stage-matched typical urothelial carcinoma treated by radical cystectomy to assess the frequency of amplification and protein expression, and to determine the association with cancer-specific survival. Read this post to learn more.
Other Posts for Research
- Flow Cytometry Immunophenotyping in Myeloid Neoplasms
- Commercial Media for Human Embryo Culture
- Reverse Sequence Screening for Syphilis
- Diagnostic Significance of Cell Kinetic Parameters in World Health Organization Type A and B3 Thymomas and Thymic Carcinomas
- Two Point of Care Devices For Capillary Lipid Screening in Fasting and Postprandial Adults
- Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders
- Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) MS for the Diagnosis of Infectious Diseases
- Detecting Herpes Simplex Virus Using a Commercial Real-Time PCR Assay
- GenomeDx, Mayo Clinic to Conduct Validation Study of Decipher® Prostate Cancer Test
- Precision and Reliability of Platelet Function Tests on Daily Antiplatelet Agent Therapy